Éric Jeziorski

ORCID: 0000-0003-0318-3044
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunodeficiency and Autoimmune Disorders
  • Blood disorders and treatments
  • Histiocytic Disorders and Treatments
  • Blood groups and transfusion
  • Parvovirus B19 Infection Studies
  • Autoimmune and Inflammatory Disorders Research
  • Platelet Disorders and Treatments
  • Streptococcal Infections and Treatments
  • Viral-associated cancers and disorders
  • Respiratory viral infections research
  • Inflammasome and immune disorders
  • Viral gastroenteritis research and epidemiology
  • Cytomegalovirus and herpesvirus research
  • Pneumonia and Respiratory Infections
  • Orthopedic Infections and Treatments
  • Vascular Malformations and Hemangiomas
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Adolescent and Pediatric Healthcare
  • Infective Endocarditis Diagnosis and Management
  • Antimicrobial Resistance in Staphylococcus
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Mycobacterium research and diagnosis
  • Diabetes and associated disorders
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Inserm
2008-2025

Université de Montpellier
2016-2025

Centre Hospitalier Universitaire de Montpellier
2015-2025

Hôpital Arnaud de Villeneuve
2015-2024

Société Française de Cardiologie
2024

Centre de Référence des Maladies Autoinflammatoires et des Amyloses
2019-2024

Établissement Français du Sang
2024

Hôpital Lapeyronie
2024

Pathogenesis and Control of Chronic and Emerging Infections
2022-2024

Sorbonne Université
2023

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with a broad spectrum of clinical manifestations and outcomes in children. The somatic BRAF(V600E) mutation occurs frequently, but significance remains to be determined.BRAF(V600E) was investigated French LCH cohort. We analyzed associations between status presentation, extent disease, reactivation rate, response therapy, long-term permanent sequelae.Among 315 patients successfully determined BRAF status, 173 (54.6%)...

10.1200/jco.2015.65.9508 article EN Journal of Clinical Oncology 2016-07-06
Alain Fischer Johan Provot Jean-Philippe Jaı̈s Alexandre Alcaïs Nizar Mahlaoui and 95 more D. Adoué Nathalie Aladjidi Zahir Amoura P. Arlet Corinne Armari‐Alla Brigitte Bader‐Meunier Vincent Barlogis Sophie Bayart Beatrice Beaurain Yves Bertrand Boris Bienvenu Stéphane Blanche Damien Bodet Bernard Bonnotte Raphaël Borie Patrick Boutard Claire Briandet Jean‐Paul Brion Carolina Brito Jacques Brouard Émilie Catherinot Olivia Chandesris Sarah Beaussant-Cohen Hélène Coignard-Biehler Laurence Costes Louis‐Jean Couderc Gérard Couillault Virginie Courteille Elodie Curlier Geneviève de Saint Basile François Deméocq Nathalie de Vergnes Catherine Devoldère Anne Deville Jean Donadieu Éric Doré Fabienne Dulieu I. Durieu C. Edan Natacha Entz Werle Claire Fieschi Fanny Fouyssac Pierre Frange Vincent Gajdos Lionel Galicier Virginie Gandemer Martine Gardembas C. Gaud B. Grosbois Gaëlle Guillerm É. Hachulla Mohamed Hamidou Sébastien Héritier Olivier Hermine C. Hoarau Bruno Hoen A. Hot S. Humbert Arnaud Jaccard Serge Jacquot Jean-Philippe Jaı̈s R. Jaussaud Pierre‐Yves Jeandel Éric Jeziorski Kamila Kébaïli Anne‐Sophie Korganow Philippe Labrune Olivier Lambotte Fanny Lanternier C. Larroche Alain Le Quellec Emmanuelle Le Moigne Vincent Le Moing Yvon Lebranchu Marc Lecuit Guillaume Lefèvre Richard Lemal Philippe Le Moine Valérie Li Thiao Te Olivier Lortholary Patrick Lutz Aude Magérus‐Chatinet Marion Malphettes Aude Marie‐Cardine Nicolas Martin Silva A. Masseau Christian Massot Françoise Mazingue Étienne Merlin Gérard Michel Frédéric Millot Odile Minckes Béatrice Monlibert Fabrice Monpoux Despina Moshous

10.1016/j.jaci.2016.12.978 article EN Journal of Allergy and Clinical Immunology 2017-02-10

Inflammasomes are multiprotein complexes that sense pathogens and trigger biological mechanisms to control infection. Nucleotide-binding oligomerisation domain-like receptor (NLR) containing a PYRIN domain 1 (NLRP1), NLRP3 NLRC4 plays key role in this innate immune system by directly assembling inflammasomes regulating inflammation. Mutations linked hereditary autoinflammatory diseases, whereas polymorphisms NLRP1 associated with autoimmune disorders such as vitiligo rheumatoid arthritis....

10.1136/annrheumdis-2016-210021 article EN Annals of the Rheumatic Diseases 2016-12-13

Background Langerhans cell histiocytosis (LCH) is a rare clonal granulomatous disease that affects mainly children. LCH can involve various tissues such as bone, skin, lung, bone marrow, lymph nodes, and the central nervous system, frequently responsible for functional sequelae. The pathophysiology of unclear, but uncontrolled proliferation cells (LCs) believed to be primary event in formation granulomas. present study was designed further investigate nature proliferating immune mechanisms...

10.1371/journal.pmed.0040253 article EN cc-by PLoS Medicine 2007-08-06

Summary The French national cohort of children with Langerhans cell histiocytosis ( LCH ) has included 1478 patients since it was established in 1983. therapeutic strategies substantially changed 1998, so we have divided the into two 15‐year periods. Starting therapy duration increased from 6 to 12 months, repeated induction performed cases showing a poor response first vinblastine and steroids, refractory disease risk organ RO +) treated cladribine cytarabine. A total 483 (33%) were...

10.1111/bjh.14140 article EN British Journal of Haematology 2016-06-07

Abstract Neurodegenerative ( ND ) complications in Langerhans cell histiocytosis LCH are a late‐onset but dramatic sequelae for which incidence and risk factors not well defined. Based on national prospective registry of paediatric patients, we determined the rate clinical cND ‐ analysed factors, taking into account disease extent molecular characteristics. Among 1897 36 (1·9%) were diagnosed with . The 10‐year cumulative was 4·1%. typically affected patients previously treated multisystem,...

10.1111/bjh.15577 article EN British Journal of Haematology 2018-11-01
Paul Bastard Sara E. Vazquez Jamin Liu Matthew T. Laurie Chung‐Yu Wang and 95 more Adrian Gervais Tom Le Voyer Lucy Bizien Colin R. Zamecnik Quentin Philippot Jérémie Rosain Émilie Catherinot Andrew Willmore Anthea Mitchell Rebecca Bair Pierre Garçon Heather Kenney Arnaud Fekkar Maria Salagianni Garyphallia Poulakou Eleni Siouti Sabina Sahanic Ivan Tancevski Günter Weiß Laurenz Nagl Jérémy Manry Sotiriјa Duvlis Daniel Arroyo‐Sánchez Estela Paz‐Artal Luis Rubio Cristiano Perani Michela Bezzi Alessandra Sottini Virginia Quaresima Lucie Roussel Donald C. Vinh Luis Felipe Reyes Margaux Garzaro Nevin Hatipoğlu David Boutboul Yacine Tandjaoui-Lambiotte A. Borghesi Anna Aliberti Irene Cassaniti Fabienne Venet Guillaume Monneret Rabih Halwani Narjes Saheb Sharif‐Askari Jeffrey J. Danielson Sonia Burrel Caroline Morbieu Yuriy Stepanovskyy Анастасія Бондаренко Алла Волоха Oksana Boyarchuk Alenka Gagro Mathilde Neuville Bénédicte Neven Sevgi Keleş Romain Hernu Antonin Bal Antonio Novelli Giuseppe Novelli Kahina Saker Oana Ailioaie Arnau Antolí Éric Jeziorski Gemma Rocamora-Blanch Carla Teixeira Clarisse Delaunay Marine Lhuillier Paul Le Turnier Yu Zhang Matthieu Mahévas Qiang Pan‐Hammarström Hassan Abolhassani Thierry Bompoil Karim Dorgham Guy Gorochov Cédric Laouénan Carlos Rodríguez‐Gallego Lisa F. P. Ng Laurent Rénia Aurora Pujol Alexandre Bélot F. Raffi Luís M. Allende Javier Martínez‐Picado Tayfun Özçelık Luisa Imberti Luigi D. Notarangelo Jesús Troya Xavier Solanich Shen‐Ying Zhang Anne Puel Michael R. Wilson Sophie Trouillet‐Assant Laurent Abel Emmanuelle Jouanguy Chun Ye

Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning antibody (Ab) response SARS-CoV-2 vaccines in individuals already at risk. Preexisting auto-Abs neutralizing type I IFNs underlie least 15% pneumonia unvaccinated individuals; their contribution hypoxemic breakthrough vaccinated people is unknown. We studied a cohort 48 (aged 20 86 years) who received two doses messenger RNA (mRNA) vaccine and developed infection with 2 weeks 4 months later. Ab levels...

10.1126/sciimmunol.abp8966 article EN cc-by Science Immunology 2022-06-14
Maria Elena Maccari Martin Wolkewitz Charlotte Schwab Tiziana Lorenzini Jennifer W. Leiding and 95 more Nathalie Aladjdi Hassan Abolhassani Wadih Abou‐Chahla Alessandro Aiuti Saba Azarnoush Safa Barış Vincent Barlogis Federica Barzaghi Ulrich Baumann Markéta Bloomfield Nadezda Bohynikova Damien Bodet David Boutboul Giorgia Bucciol Matthew Buckland Siobhan O. Burns Caterina Cancrini P. Cathébras Marina Cavazzana Morgane Cheminant Matteo Chinello Peter Čižnár Tanya Coulter Maud D’Aveni Olov Ekwall Želimir Erić Efrem Eren Anders Fasth Pierre Frange Benjamin Fournier Marina García-Prat Martine Gardembas Christoph B. Geier Sujal Ghosh Vera Goda Lennart Hammarström Fabian Hauck Maximilian Heeg Edyta Heropolitańska–Pliszka Anna Hilfanova Stephen Jolles Elif Karakoç-Aydıner Gerhard Kindle Ayça Kıykım Christian Klemann Patra Koletsi Sylwia Kołtan Irina Kondratenko Julia Körholz Renate Krüger Éric Jeziorski Romain Lévy G. Le Guenno Guillaume Lefèvre Vassilios Lougaris Antonio Marzollo Nizar Mahlaoui Marion Malphettes Andrea Meinhardt Étienne Merlin Isabelle Meyts Tomáš Milota Fernando Moreira Despina Moshous Anna Mukhinа Olaf Neth Jennifer Neubert Bénédicte Neven Alexandra Nieters R. Nové-Josserand Éric Oksenhendler Ahmet Özen Peter Olbrich Antoinette Perlat Małgorzata Pac Jana Pachlopnik Schmid Lucia Pacillo Alba Parra-Martínez Olga Paschenko Isabelle Pellier Asena Pınar Sefer Alessandro Plebani Dominique Plantaz Seraina Prader L. Raffray Henrike Ritterbusch Jacques G. Rivière Beatrice Rivalta Stephan Rusch Inga Sakovich Sinisa Savic Raphael Scheible N. Schleinitz Catharina Schuetz Ansgar Schulz

10.1016/j.jaci.2023.06.015 article EN Journal of Allergy and Clinical Immunology 2023-06-28

Abstract The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications are not fully characterized, especially for non‐Langerhans cell histiocytosis (‐LCH) subtypes. A cohort 415 children with from the French registry was reviewed analyzed BRAF V600E . Most WT samples were by next‐generation sequencing (NGS) a custom panel genes myeloid neoplasia. Of case samples, there 366 LCH, 1 Erdheim‐Chester disease, 21 Rosai‐Dorfman disease (RDD), juvenile xanthogranuloma...

10.1002/ajh.26938 article EN cc-by-nc American Journal of Hematology 2023-04-28

An expanding number of monogenic defects have been identified as causative severe forms very early-onset inflammatory bowel diseases [VEO-IBD]. The present study aimed at defining how next-generation sequencing [NGS] methods can be used to improve identification known molecular diagnosis and adapt treatment.A total 207 children were recruited in 45 paediatric centres through an international collaborative network [ESPGHAN GENIUS working group] with a clinical presentation VEO-IBD [n = 185]...

10.1093/ecco-jcc/jjy068 article EN cc-by-nc Journal of Crohn s and Colitis 2018-05-16

Background. About 10% of pediatric patients with invasive pneumococcal disease (IPD) die from the disease. Some primary immunodeficiencies (PIDs) are known to confer predisposition IPD. However, a systematic search for these PIDs has never been carried out in children presenting Methods. We prospectively identified cases IPD requiring hospitalization between 2005 and 2011 28 wards throughout France. was defined as positive culture, polymerase chain reaction result, and/or soluble antigen...

10.1093/cid/ciu274 article EN Clinical Infectious Diseases 2014-04-23

The BRAFV600E mutation is reported in half of patients with Langerhans cell histiocytosis (LCH). This study investigated the detection allele circulating cell-free (ccf) DNA a paediatric LCH cohort. Children -mutated were to detect ccf at diagnosis (n = 48) and during follow-up 17) using picolitre-droplet digital PCR assay. At diagnosis, was positive 15/15 (100%) risk-organ multisystem (RO+ MS) LCH, 5/12 (42%) RO- MS 3/21 (14%) single-system (SS) (P < 0·001, Fisher's exact test). load higher...

10.1111/bjh.14695 article EN British Journal of Haematology 2017-04-25

Evans syndrome (ES) is a rare autoimmune disorder whose long-term follow-up characteristics are unknown. Patients under 18 at the time of diagnosis first cytopenia have been included since 2004 in national prospective observational cohort. In 2014, 156 children diagnosed between 1981 and 2014 with ES, were analyzed. The median age initial was 5.4 (0.2-17.2) years old. For 85 sequential cases, delay episodes AIHA ITP 2.4 (0.1–16.3). ES 6.5 (0.1-28.8). revealed underlying diseases 10%...

10.3389/fped.2015.00079 article EN cc-by Frontiers in Pediatrics 2015-09-29

The purpose of this study was to describe the natural history severe congenital neutropenia (SCN) in 14 patients with G6PC3 mutations and enrolled French SCN registry. Among 605 included registry, we identified 8 pedigrees that autosomal recessive mutations. Median age at last visit 22.4 years. All had developed various comordibities, including prominent veins (n = 12), cardiac malformations intellectual disability 7), myopathic syndrome recurrent painful cramps 1). Three Crohn's disease,...

10.1186/s13023-014-0183-8 article EN cc-by Orphanet Journal of Rare Diseases 2014-12-01

Langerhans cell histiocytosis (LCH) is a rare disease that affects mainly young children, and which features granulomas containing Langerhans-type dendritic cells. The role of several human herpesviruses (HHV) in the pathogenesis LCH was suggested by numerous reports but remains debated. Epstein-barr virus (EBV, HHV-4), & Cytomegalovirus (CMV, HHV-5) can infect cells, EBV, CMV HHV-6 have been proposed to be associated with based on detection these viruses clinical samples.We investigated...

10.1371/journal.pone.0003262 article EN cc-by PLoS ONE 2008-09-22
Coming Soon ...